Neuropsychiatry

Neopharmed Gentili’s efforts in Neuropsychiatry are focused on supporting those faced with such challenges as cognitive decline, insomnia, anxiety, depression, and mood disorders.

Cognitive decline can significantly influence fundamental aspects of daily life, such as memory and language, compromising the quality of life of the individual and that of the caregivers helping them.

Insomnia, on the other hand, manifests as both an objective and subjective deterioration in the quality of sleep of an individual, characterized by difficulties falling asleep, waking up during the night or waking up prematurely in the early morning, often leading to a state of chronic tiredness during the day. Instead, disorders such as anxiety and depression can severely interfere with daily life, darkening the thoughts, mood, and behavior of those suffering from them.

Managing and slowing down the progression of these disorders is made possible thanks to tailor-made and targeted treatments, which results in improved quality of life for both the individual and their caregiver.

This is what constantly motivates Neopharmed Gentili’s commitment, always in search of solutions that are both effective and mindful of the needs of those facing these challenges.

HCP

Organized by therapeutic areas, in this section, accredited physicians can download all informational materials and specific updates related to each medicine distributed by Neopharmed Gentili.

READ ALL INFORMATION AND SERVICES

HISTORY

We are an Italian pharmaceutical company that has historically operated within national borders, and we are currently in the process of expanding internationally.

LEARN MORE